HPSE and sarcoma: The reported data, demonstrating a multi-target inhibitory effect on activation of coexpressed and often interconnected RTKs crucial in the pathobiology of different sarcoma subtypes, reveals a new aspect, likely cooperating with heparanase inhibition, of the antitumor activity of the HS mimic roneparstat.